Volume 10, Number 6—June 2004
Research
Quinolone-resistant Campylobacter Infections in Denmark: Risk Factors and Clinical Consequences1
Table 1
Species | Quinolone-resistant isolates |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total no. (N = 1,204) | Human (n = 678) |
Food (n = 180) |
Broiler chickens (n = 49) |
|||||||
Travel (n = 152) |
Domestic (n = 526) |
|||||||||
No. | (%) | No. | (%) | No. | (%) | No. | (%) | |||
C. jejuni |
1,118 |
137 |
48.2 |
506 |
9.9 |
153 |
8.5 |
39 |
5.2 |
|
C. coli |
79 |
15 |
66.7 |
14 |
7.1 |
27 |
29.6 |
10 |
– |
|
C. lari |
1 |
0 |
– |
1 |
100 |
0 |
– |
0 |
– |
|
C. spp.a |
6 |
0 |
– |
1 |
20 |
0 |
– |
0 |
– |
|
Total | 1,204 | 152 | 50.0 | 526 | 9.9 | 180 | 13.7 | 49 | 5.2 |
aSpeciation not performed.
1This study was presented in part at the 12th International Workshop on Campylobacter, Helicobacter and Related Organisms, September 6–10, 2003, Aarhus, Denmark.
2Current affiliation is Statens Serum Institut, Copenhagen, Denmark.
3Current affiliation is Danish Toxicology Centre, Hørsholm, Denmark.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.